50-98-6CN[C@@H](C)[C@H](O)c1ccccc1.ClBALXUFOVQVENIU-GNAZCLTHSA-NEphedrine hydrochloride is an alkylbenzene.
50-98-6DTXSID1045825CHEMBL2146102CHEBI:31541FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 114 reports by companies from 7 notifications to the ECHA C&L Inventory.
Status: Active Update: 08-11-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/10058
Ephedrine hydrochloride: Does not have an individual approval but may be used under an appropriate group standard
EPHEDRINE HYDROCHLORIDE
Increased Norepinephrine Activity [PE]; Norepinephrine Releasing Agent [EPC]; Adrenergic beta-Agonists [MoA]; Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.
Drugs used to cause constriction of the blood vessels.
Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters.
Loading…